Unlike the way the space program started, NASA will not be racing a competitor. Rather, we will build upon the community of industrial, international, and academic partnerships forged for the space station.

1 Follower

NASA’s future will continue to be a story of human exploration, technology, and science. We will go back to the Moon to learn more about what it will take to support human exploration to Mars and beyond. We will continue to nurture the development of a vibrant low-Earth orbit economy that builds on the work done to date by the International Space Station. NASA engineers will develop new technologies to improve air transport at home and meet the challenges of advanced space exploration. Our scientists will work to increase an understanding of our planet and our place in the universe. We will continue to try to answer the question, “Are we alone?”

Best Industrial Automation Parts Seller in Bangladesh

1 Follower

Best of Industrial Machinery Parts Supplier & Automation Products sales service & Importer in the Bangladesh. We are now providing many kinds of automation product support all over Bangladesh. Now we provide many services like Industrial Automation product sales and repair, Industrial Automation programming, etc. If you are looking for any industrial automation spare parts for your industry you are in right place. We can help you to solve your problem with our premium services.

Canadian phase 2 clinical trial, recruiting patients.

0 Followers

C Difficile is a gram positive spore forming bacteria, which can cause severe gut infection. It infects and kills 500,000 and 30,000 North Americans respectively every year. Standard of care treatment is Vancomycin antibiotic, which is effective in 60 to 70% of cases. When unsuccessful, the infection can recur and likeliness of recurrence increases after every treatment failure. Its treatment is considered an unmet medical need by the FDA and as such new treatments showing positive potential are typically fast tracked. ImmuniMed Inc, a Canadian clinical stage Biopharmaceutical company is presently in phase 2 clinical trial of its oral dose antibody treatment and recruiting patients. If you are a Canadian resident, over the age of 18 and have tested positive for c Difficile, please contact us to participate in this trial. John Hare John@immunimed.com 204-955-8495